Patient Participation

By decentralizing trials whenever feasible, sites can decrease patient burden, clinops workload, and the number of on-site participants.

In this interview, Patrice Matchaba, MD, President of Novartis US Foundation discusses how the biopharmaceutical industry can regain the trust of minorities.

Looking beyond regulatory compliance.

In light of Facebook ban on ads targeting patients, industry has chance to reinvent digital advertising for trials.

Helping physicians and patients discuss local trials at the point of care.

While eConsent has become more widely adopted since COVID-19, work still needs to be done in improving patients’ understanding.

Five strategies to reduce risk and achieve deadlines.

Sponsors can ensure higher retention by partnering with patient support services.

Exploring their unique opportunity in increasing study enrollment levels.

Understanding differences in studies, sites, and patients are key to making eConsent successful.

In an era of rising healthcare expenses, reassurance about costs for patients in diverse communities is particularly important.

Assessing the benefits of digital adherence monitoring for sites and patients.

Latest CISCRP study provides insight on proactive outreach.

Breaking down the barriers to eConsent adoption.

Industry must work closely with patients to advance the use of decentralized technology.

Reminding clinical research stakeholders to reprioritize routine assessment of patient satisfaction as a primary outcome measure in patient-centric activities.

Tony Clapsis, SVP, Clinical Trials Services, CVS, discusses recent advancements in the clinical trials space by CVS.

Keys to ensuring your clinical trials better reflect your target population.

The approach of the Cancer Research UK Centre for Drug Development.

Phase I/II study in cancer patients showcases eClinical effectiveness.

Survey uncovers pediatric-patient perspectives on plain language summaries.

Darcy Flora, PhD, chief research officer of GRYT Health, a digital oncology company, discusses her career, the company, and drug development.

Meeting patients at the point of care can increase trust and engagement.